{"id":"https://openalex.org/W2886847252","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","title":"SAT0177 Real-world interruptions in janus kinase inhibitor therapy observed among biologic-na\u00cfve and biologic-experienced rheumatoid arthritis patients","display_name":"SAT0177 Real-world interruptions in janus kinase inhibitor therapy observed among biologic-na\u00cfve and biologic-experienced rheumatoid arthritis patients","publication_year":2018,"publication_date":"2018-06-01","ids":{"openalex":"https://openalex.org/W2886847252","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","mag":"2886847252"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2018-eular.3456","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/949.2.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/949.2.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010975448","display_name":"Benjamin J. Chastek","orcid":"https://orcid.org/0000-0002-9759-6001","observed_orcids":["https://orcid.org/0000-0002-9759-6001"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Chastek","raw_affiliation_strings":["Optum, Eden Prairie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum, Eden Prairie","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088923735","display_name":"Eleena Koep","orcid":"https://orcid.org/0000-0003-4002-996X","observed_orcids":["https://orcid.org/0000-0003-4002-996X"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Koep","raw_affiliation_strings":["Optum, Eden Prairie"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optum, Eden Prairie","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068662580","display_name":"Usha G. Mallya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U.G. Mallya","raw_affiliation_strings":["Sanofi, Bridgewater"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Bridgewater","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083308261","display_name":"Alex R Cockerham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Cockerham","raw_affiliation_strings":["Sanofi, Bridgewater"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Bridgewater","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055151340","display_name":"Jeannie Choi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Choi","raw_affiliation_strings":["Sanofi, Bridgewater"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi, Bridgewater","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003254447","display_name":"Susan Boklage","orcid":"https://orcid.org/0000-0003-2356-5533","observed_orcids":["https://orcid.org/0000-0003-2356-5533"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Boklage","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059206584","display_name":"Daniel E. Furst","orcid":"https://orcid.org/0000-0001-7857-2373","observed_orcids":["https://orcid.org/0000-0001-7857-2373","https://orcid.org/0000-0002-4018-7629"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT","US"],"is_corresponding":false,"raw_author_name":"D.E. Furst","raw_affiliation_strings":["University of California Los Angeles, Los Angeles","University of Florence, Florence, Italy","University of Washington, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Los Angeles, Los Angeles","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"University of Florence, Florence, Italy","institution_ids":["https://openalex.org/I45084792"]},{"raw_affiliation_string":"University of Washington, Seattle, United States","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":null,"first_page":"949","last_page":"950"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/treatment-interruption","display_name":"treatment interruption","score":0.6190000176429749},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.6480000019073486},{"id":"https://openalex.org/keywords/biologic-naive-patients","display_name":"biologic-naive patients","score":0.8320000171661377},{"id":"https://openalex.org/keywords/biologic-experienced-patients","display_name":"biologic-experienced patients","score":0.9900000095367432},{"id":"https://openalex.org/keywords/biologic-switching","display_name":"biologic switching","score":0.640999972820282},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.5460000038146973},{"id":"https://openalex.org/keywords/real-world-prescribing-patterns","display_name":"real-world prescribing patterns","score":0.5789999961853027},{"id":"https://openalex.org/keywords/medicare-advantage","display_name":"Medicare Advantage","score":0.6209999918937683},{"id":"https://openalex.org/keywords/private-insurance","display_name":"private insurance","score":0.39500001072883606},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.42800000309944153},{"id":"https://openalex.org/keywords/disease-modifying-antirheumatic-drugs","display_name":"disease-modifying antirheumatic drugs","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.939504861831665},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8045704364776611},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7638197541236877},{"id":"https://openalex.org/C2776233030","wikidata":"https://www.wikidata.org/wiki/Q17149812","display_name":"Janus kinase inhibitor","level":4,"score":0.7310934066772461},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5450182557106018},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5446533560752869},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5284259915351868},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.5174899101257324},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.45547083020210266},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1790558099746704},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.1206226646900177}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2018-eular.3456","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/949.2.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2018-eular.3456","doi":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2018-eular.3456","pdf_url":"https://ard.bmj.com/content/annrheumdis/77/Suppl_2/949.2.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2886847252.pdf","grobid_xml":"https://content.openalex.org/works/W2886847252.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W1587254048","https://openalex.org/W2541158052"],"related_works":["https://openalex.org/W4283697913","https://openalex.org/W4401775846","https://openalex.org/W4393005125","https://openalex.org/W4394684066","https://openalex.org/W4409449211","https://openalex.org/W4367721064","https://openalex.org/W4391576510","https://openalex.org/W4396669783","https://openalex.org/W4367721085","https://openalex.org/W7202299541"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2018-08-22T00:00:00"}